Human Umbilical Cord Derived-Mesenchymal Stem Cells (Zhongnan Hospital)

人脐带源间充质干细胞（武汉大学中南医院）

Report date: 2023/01/12 15:41:05

Base Information

Drug NameHuman Umbilical Cord Derived-Mesenchymal Stem Cells (Zhongnan Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhongnan Hospital Of Wuhan University
China Registration ClassN/A

Develop Information

Active CompaniesZhongnan Hospital Of Wuhan University
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A